Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality (Q43577899)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2002

Language	Label	Description	Also known as
English	Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality	scientific article published in December 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Herman Waldmann

object named as

H Waldmann

7

0 references

8

object named as

Geoff Hale

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

12

object named as

David C Linch

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Anthony H. Goldstone

11

object named as

Anthony H Goldstone

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

object named as

Irit Avivi

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Panagiotis D Kottaridis

5

object named as

Panagiotis D Kottaridis

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Suparno Chakrabarti

1

object named as

Suparno Chakrabarti

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

10

object named as

Kwee Yong

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Stephen Mackinnon

3

object named as

Stephen Mackinnon

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

6

object named as

Husam Osman

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Christopher Fegan

9

object named as

Christopher D Fegan

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Kate Ward

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Donald W Milligan

13

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

119

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1125-1132

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Non-myeloablative stem cell transplants

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory viral infections in immunocompetent and immunocompromised persons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Community respiratory viruses in individuals with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Community respiratory virus infections in immunocompromised patients with cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2002.03992.X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43577899&oldid=2101605500"